REMEDIUM

The activities of all institutions and organizations can be carried out only with appropriate financial support, material and technical equipment. All financial activities of state institutions depend on the current laws, by-laws and regulatory framework of the Russian Federation. Purpose. analysis of financing and logistics of the Federal State Budgetary Institution Center of Hygiene and Epidemiology (CHaE) for 2011—2020. Methods. We used the method of retrospective analysis to study the financing and logistical support of the FSBI CHaE. The following methods were used in the course of the study: study, generalization, analytical, statistical — descriptive statistics, mathematical method.retrospective, analytical, mathematical, economic. Results. The increase in expenses occurs during mass events and during the COVI-19 epidemic. In 2013, the expense was 17,742,645 rubles; In 2015, the expense was 50,585,971 rubles; In 2017, the expense was 156,665,323 rubles; in 2018 and 2019, the expense was less than in 2017, due to the high costs in the previous year. In 2020, during the COVID-19 epidemic, the center's expenses increased to 256,855,799 rubles. In order to introduce modern technologies of qualitative and quantitative analysis, equipment for laboratory units is purchased every year. If in 2011 the cost of purchasing laboratory equipment was 84,083,140 rubles from budget money, then in 2020 144,113,000 rubles were spent, which indicates the improvement of equipment and an increase in their prices. During the preparation and holding of mass events and during the COVID-19 pandemic, the federal budget allocates more than 50% of funding for the remuneration of employees of the CHaE. Conclusion. During the preparation and holding of mass events and during the pandemic of COVID-19, the CHaE has adequate federal funding. The material and technical support of the center is improved annually in order to introduce modern technologies of qualitative and quantitative analysis.

The study examined the attitude of pharmaceutical workers towards the purchase of medicines by adolescents. 185 people took part in the survey; 34.6% of respondents have never encountered difficulties in pharmaceutical counseling of adolescents. 58.4% of respondents rarely had difficulties in counseling, 7% of survey participants often had difficulties. Regardless of the level of education, only 7.1% of specialists (both pharmacists and pharmacists) noted that they face difficulties in pharmaceutical counseling. Experience also does not have any significant impact on the decision-making by a specialist. At the same time, respondents with the longest experience — more than 10 years — most often experienced difficulties (about 9% of cases) in counseling adolescents. The main difficulty faced by pharmaceutical workers in counseling adolescents is difficulties in formulating a request by a teenager (48.1%) and indecision of adolescents in making a decision (28.7%).

The development of digital technology is increasing the number of ways in which pharmaceutical care can be provided, and therefore its accessibility. One of the key areas of this development is telepharmacy, the application of which is relevant both abroad and in Russia. The experience of introducing telepharmacy services differs from country to country. In our country, services such as remote ordering of drugs and remote counselling with a pharmaceutical specialist are particularly developed. An analysis was conducted of mobile applications and websites of online services for remote ordering and delivery of medicines, dietary supplements and other pharmacy products.

The article is dedicated to N. F. Zdekauer, a Russian therapist and public figure. He promoted the introduction of physical examination methods into clinical practice. He was a supporter of hygienic method of treatment of tuberculosis and aerotherapy. He was one of the founders of Russian Society for Public Health Protection and its long-time chairman. Initiator of the I All-Russian hygienic exhibition of 1893.

The sudden outbreak of the COVID-19 epidemic has given more significant attention to solving the problem of acute respiratory viral infections. In this regard, the Ministry of Health of the Russian Federation and the Federal Service for Supervision of Consumer Rights Protection and Human Well-Being have issued Temporary Guidelines for the prevention, diagnosis and treatment of new coronavirus infection, which are of interest to practitioners of the healthcare system. The purpose of this study is to conduct a comparative analysis of the stages of administration of drugs for the treatment of COVID-19 in adults. We have analyzed the medicines recommended by the Temporary Guidelines for the treatment of COVID-19 in adults for the period from 29.01.2020 to 18.08.2022. The structural analysis of the membership of drug groups for the treatment of COVID-19 according to the anatomical-therapeutic-chemical classification was carried out. Medicines were divided into groups and subgroups depending on their effect on a certain anatomical organ or system.

Today in cervical cancer diagnostics special attention is paid to the identification of a cohort of women with relatively high risk for the disease development among general population. The objective of the study was development and evaluation of possible prognostic criteria for treatment tactics determination in women with cervical diseases. Based on the data obtained by the method of intensive indicators normalization, a scale for risk prediction of cervical cancer development was formed and its effectiveness was evaluated. Our analysis demonstrated feasibility of introducing into clinical practice a method for cervical cancer developing risk assessment with a four-degree prognostic scale based on a comprehensive examination. This research could contribute to an evidence-based medical decision-making in management of patients with abnormal primary examination results; help in shortening the diagnostic interval for cervical diseases verification of; as such as increase the effectiveness of cervical cancer secondary prevention.

The problem of ensuring the quality and safety of medical care in Russian healthcare is being solved both at the institutional and practical levels, for which the Russian Ministry of Health has developed special requirements for organizing and conducting internal control of quality and safety indicators. At the same time, statistics show that the life expectancy of the population in Russia is declining, which is due, on the one hand, to the negative consequences of the COVID-19 epidemic, and, on the other hand, to the accumulated problems in ensuring the quality and safety of medical care at the level of medical organizations. This requires the improvement of approaches to the organization and conduct of internal control of these indicators. The purpose of the study: to present an express assessment of the quality and safety of medical care to the population in Russia in terms of the dynamics of life expectancy and criminal cases against medical workers who failed to ensure the high quality and safety of care provided to patients in the performance of their professional duties. Suggest approaches to improve the organization and conduct of internal control of the quality and safety of medical care in medical organizations. Materials and methods. When presenting the materials of the article, methods of statistical analysis of public data on the dynamics of life expectancy and on the dynamics of initiating criminal cases against medical workers were used. These data were used as the basis for the study of the hypothesis about the impact of the quality and safety of medical care on the life expectancy of the population. Also, the methods of content analysis of legal acts and methods of scientific synthesis were used in the work, which made it possible to form recommendations and methodological provisions for the analysis and improvement of internal control of the quality and safety of medical care. Results. The COVID-19 epidemic leveled the upward trend in life expectancy of the Russian population (an overall reduction of 5% in 2021 compared to 2019). This is the result of the contribution of defects in the provision of medical care and medical errors. Not the last role in the reduction of life expectancy was played by the low professional competence of some groups of medical workers, which is especially clearly manifested in the regions. Conclusion. A simplified approach has been developed to routine checks of the quality and safety of medical care within the framework of internal control, regulated by the order of the Ministry of Health of Russia dated July 31, 2020 No. 785n. The approach is based on the use of a system of indicators determined by the institutional triad: timeliness of provision, correct choice of medical interventions, results of assistance. To evaluate the indicators, a weight-point method is proposed that allows you to obtain a preliminary conclusion on the state of the quality and safety of medical care in an organization and only after that proceed to extended scheduled and targeted (unscheduled) checks, regulated by order of the Ministry of Health of Russia dated July 31, 2020 No. 785n.

The information’s stand (IS) in a pharmacies is a high-frequency object of study and control, both by inspectors and visitors, and the way information is presented on it is important from the point of view of compliance with legal norms and customer loyalty. The purpose of this work was to identify the most common inconsistencies of the components of the IS of the pharmacies and to analyze the risks arising from incorrect registration of the IS. As a result of the conducted research, a low level of attention to filling the IS with both mandatory and additional information was established. In order to minimize the risks arising from incorrect design of the IS, a standard operating procedure, a sample checklist, including all mandatory and additional items, and an IS layout have been developed, these materials are available for download via the QR code in the article.

Systematic changes in healthcare and a deep understanding of the value of human life, the well-being of people, as well as the impact of the use of medicines have led to the identification of criteria for the relative value of medicines. The article presents lists and precise textual formulations of criteria for the relative value of medicines. Some basic requirements for the criteria of the relative therapeutic value of medicines are formulated, their potential mutual influence is assessed, and formulations of questions are proposed to collect expert opinion on the significance of the criteria of the relative value of medicines.